chrisvoncsefalvay/vaers-outcomes huggingface dataset:
booster dose; swollen on her neck or her arm comparable to the size of a baseball ball; swollen on her neck or her arm comparable to the size of a baseball ball; she is only seeing less inflammation as of today 07DEC2021; When will my daughter's lymph nodes return back to normal; had reaction and was very uncomfortable for the booster/ there was a reaction to this booster so badly; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 38 year-old female patient received bnt162b2 (BNT162B2), administration date 01Dec2021 (Batch/Lot number: unknown) at the age of 38 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, For the first two doses, we did not experience any adverse events".), for Covid-19 Immunization, reaction(s): "did not experience any adverse events"; Bnt162b2 (2nd dose, For the first two doses, we did not experience any adverse events".), for Covid-19 Immunization, reaction(s): "did not experience any adverse events". The following information was reported: IMMUNISATION (non-serious) with onset 01Dec2021, outcome "unknown", described as "booster dose"; SWELLING (non-serious), PERIPHERAL SWELLING (non-serious) all with onset Dec2021, outcome "unknown" and all described as "swollen on her neck or her arm comparable to the size of a baseball ball"; INFLAMMATION (non-serious) with onset Dec2021, outcome "recovering", described as "she is only seeing less inflammation as of today 07DEC2021"; LYMPHADENOPATHY (non-serious) with onset Dec2021, outcome "not recovered", described as "When will my daughter's lymph nodes return back to normal"; FEELING ABNORMAL (non-serious) with onset Dec2021, outcome "unknown", described as "had reaction and was very uncomfortable for the booster/ there was a reaction to this booster so badly".  Additional information: The Pfizer-BioNTech COVID-19 Vaccine is authorized for use as a single booster dose to individuals 18 years of age and older who have completed a primary series with Pfizer-BioNTech COVID-19. Fever, headache, fatigue, and pain at the injection site were the most reported side effects, and overall, most side effects were mild to moderate. However, as with the two-shot or single-dose primary series, serious side effects are rare, but may occur. In a clinical study of participants 18 through 55 years of age, adverse reactions following administration of a booster dose included lymphadenopathy (5.2%), nausea (0.7%) and rash (0.3%). In an analysis of all unsolicited adverse events reported following the booster dose, through 1 month after the booster dose, in participants 18 through 55 years of age (N = 306), those assessed as adverse reactions not already captured by solicited local and systemic reactions were lymphadenopathy (n = 16, 5.2%), nausea (n = 2, 0.7%) and rash (n = 1, 0.3%)".  The lot number for bnt162b2 was not provided and will be requested during follow up.
had erythema 40mm x 45mm only-no induration-@ site of inject 10 mins p/shot; given DPH & tolerated well; erythema dec to 30 x 25 mm 10 mins p/given DPH; no induration, pruritus, or resp complaints;
Information has been received from a physician concerning his 74 year old wife who on 10/02/03 was vaccinated with a third dose of pneumococcal 23v polysaccharide vaccine (Lot # 644220/1119M). Concomitant therapy included alendronate sodium and aspirin. It was noted that the pt received the second dose of pneumococcal 23v polysaccharide in 1984. After vaccination the pt experienced chills, a fever of 102.6, vomiting and paresthesia (date not specified). The reporter indicated that 12 days after vaccination the pt was taken to the ER and extensive tests were performed. A chest x-ray was normal, a rapid strep test was positive, and a blood culture revealed polymorphonuclear leukocytes 81%, lymphocytes 15%, and monocytes 2%. The pt was not admitted to the hospital but was treated with erythromycin and azithromycin (Z-pak). The client was recovering but had a relapse of fever and was hospitalized on 10/23/03 for four days. Extensive tests were taken including an ultrasound of the gall bladder, abdomen and pelvis (results not reporter), two blood cultures (results not reported), an erythrocyte sedimentation rate which was normal, and an echocardiogram which was normal but with some calcification.  The pt was released from the hospital on 10/27/03 with a discharge diagnosis of fever of unknown origin. It was noted that the event abated and the pt was recovering with sequelae. A product quality complaint was not involved. Follow up information was received from a nurse in the physician's office. The reporter indicated that the physician felt that the pt's symptoms had nothing to do with the pneumococcal 23v polysaccharide vaccine. The reporter noted that the pt had been having "problems" before the vaccination because of cat bites that she had received and was on an antibiotic because of the bites. The office had not heard from the pt since 10/03 and it was assumed that the pt had recovered. Additional information has been requested.
So on March 3 2021 I went to the urgent care and saw the DR due to pain in the lower left quadrant. The DR said it was diverticulitis and prescribed me two antibiotics. The pain continued and I went back to the DR on March 8. The DR sent me to the Hospital for an MRI. I was then sent for a follow up CT scan. I went back to the DR and there was a confirmed spot, so I was scheduled for a biopsy. I went in in April 2021 and had the cancer removed and go in November 2021 for a follow up biopsy and renal cell dual CT.
Seizure like episodes.; Dizzy spells; High ammonia levels of 267 at the highest; Hit uric acid; She can not walk; Numbness on her right side; Terrible headache; Nausea; This is a spontaneous report from a contactable consumer.  A female patient (mother) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The reporter wanted to write because the patient (mother) has been in the hospital almost 18 days with no end in sight. She is going to a rehab facility soon. She had a terrible reaction to the vaccine and the reporter thought it should be noted somewhere. She is an interesting case because lots of things react bad with her. She has dizzy spells, seizure like episodes, high ammonia levels of 267 at the highest, hit uric acid, she can not walk, numbness on her right side, terrible headache, nausea and more from an unspecified date. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Her arm hurt a little bit; fever; nausea appeared again; Diarrhea appeared again/diarrhea; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm hurt a little bit), DIARRHOEA (Diarrhea appeared again/diarrhea), NAUSEA (Nausea), PYREXIA (fever) and NAUSEA (nausea appeared again) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, the patient experienced DIARRHOEA (Diarrhea appeared again/diarrhea) and NAUSEA (Nausea). On 31-Aug-2021, the patient experienced PYREXIA (fever) and NAUSEA (nausea appeared again). On an unknown date, the patient experienced PAIN IN EXTREMITY (Her arm hurt a little bit). On 30-Aug-2021, NAUSEA (Nausea) had resolved. At the time of the report, PAIN IN EXTREMITY (Her arm hurt a little bit), DIARRHOEA (Diarrhea appeared again/diarrhea), PYREXIA (fever) and NAUSEA (nausea appeared again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information was provided.
Third day of fever aches chills and muscle pain.  Temps vary from 99 degrees to 103.1.
Pain in the left arm, headache, and fever (100 F), relieved in about 24 hours
Breakthrough case admission after 4 vaccines Moderna 1/11/21 Lot# 032H20A;  Moderna 2/8/21 Lot# 032H20A;  Moderna 12/2/21 Lot# 029H21B;  Moderna 6/3/22 Lot# 059M21A
Headache, fever, extreme pain at injection site, limited use of arm, arm hurts to touch.
This spontaneous report as received from a current 63 years male consumer reporting on himself with no allergies or pertinent medical history who last week on 16-SEP-2013 was vaccinated with a dose of ZOSTAVAX, subcutaneous (dose and lot number not provided). There were no concomitant medications provided. On an unknown date the patient experienced site tenderness and injection site warmth after receiving ZOSTAVAX. There was no treatment given for the events. There were no labs performed. The outcome of injection site tenderness and injection site warmth was reported as recovering on therapy. The patient did not seek medical attention. Additional information has been requested.
Nose rinse; excessively losing her hair; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Nov2021 12:15 (Lot number: FH8030) as dose 2, single for covid-19 immunisation. Relevant medical history included: "COVID", stop date: 25Aug2021, notes: After recovering from Covid 25Aug2021, I recovered my since of taste, smell back. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose: , Lot: FF2593, Dosage text: Injection in the left arm for both doses), administration date: 25Oct2021, for Covid-19 Immunization, reaction(s): "altered taste", "smell horrible", "nauseous". The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "not recovered", described as "excessively losing her hair"; NASAL DISCOMFORT (non-serious), outcome "unknown", described as "Nose rinse". Therapeutic measures were taken as a result of nasal discomfort.  Additional information: It was reported that caller said that she had noticed losing hair within the last 3 weeks. No prior vaccinations within 4 weeks. No family Medical History Relevant to AE(S). no relevant Test or specific relevant test for Thromboembolic events with Thrombocytopenia. It was reported that after receiving first dose a few days after I noticed an altered taste and smell. Coffees, chocolate, voxmery, peppermint down, dove soap, deodorant just to remove a few smell horrible that it causes me to nauseous. If I drink coffee, eat chocolate or teas the taste was so bad. I've thought long and hard on how to describe. burnt oil l geese, smoke. This was 24/7. Paste with meat sauce has zero flavour. After receiving second dose same symptoms no improve meat.  No follow-up attempts are possible. No further information is expected.  Follow-Up (06Dec2021): Follow-up attempts are completed. No further information is expected.
Severe joint pain in right ankle. Immobilized with pain, severe swelling, and joint instability for three days initially, but problem still persists months later.
Hives one day after vaccination on 8/17/22 Taken to urgent care & prescribed Benadryl
Anxiety attack. Prior to receiving vaccine, pt had altercation with front desk staff. Pt has a history of becoming upset with staff and hyperventilating. EMS was called. Pt collapsed to floor screaming repeatedly: "I can't breathe!" O2 sat was 99% throughout episode. EMS transported pt to hospital.
still got the flu; Initial information received on 27-Dec-2022 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves a patient of unknown age and gender who reported still got the flu after receiving influenza vaccine.  It is unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient had received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, route, formulation, batch number and expiry date: unknown) in unknown administration site for flu (influenza).  On an unknown date, the patient reported still got the flu (influenza) (latency: unknown) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event.   At time of reporting, the outcome was Unknown for the event.
Administered expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.   No treatment medications were provided.
Right upper arm 5 x 4 cm erythema, indurated, slightly tender no fev.
Antibodies were extremely low; This spontaneous case was reported by a consumer and describes the occurrence of DRUG SPECIFIC ANTIBODY ABSENT (Antibodies were extremely low) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOFACITINIB CITRATE (XELJANZ XR) for Psoriatic arthritis.    No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started TOFACITINIB CITRATE (XELJANZ XR) (unknown route) 11 milligram. On an unknown date, the patient experienced DRUG SPECIFIC ANTIBODY ABSENT (Antibodies were extremely low). At the time of the report, DRUG SPECIFIC ANTIBODY ABSENT (Antibodies were extremely low) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: low (Low) Antibodies were extremely low.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were provided.  Treatment medications were unknown.  The patient received Xeljanx XR 11mg for psoriatic arthritis and the patient was immunocompromised. The patient had Moderna Covid vaccine on 05-MAR-2021 and 11-APR-2021 and recently had an antibody test and her antibodies were extremely low. The patient's doctor thinks the patient should get the Pfizer covid vaccine but wanted her to be off the Xeljanz before the patient takes it and wait two weeks before the patient starts it again.   This case was linked to MOD-2021-187597 (Patient Link).
felt fine after the shot at 4:45pm.  the next morning around 10:30am I began experiencing black-out episodes when I would move my head to look over my shoulder, look to either side of the room.  When I got up from sitting to walk to the bathroom, my legs were wobbly as if I was going to fall.  I also developed a severe headache that lasted 3 days.  The black-outs ended after 12 hours.  Then Tuesday-Friday I had the "expected" feel like the flu hit me.
On 11/23/2022, I had been feeling fine and getting ready to go to my family's for the holiday. The day before, all of sudden, I had a bad sore throat. My nose started running and had an instant cold. That never happens to me. I thought right away maybe this was COVID-19 because it was different. As the day went on, it got worse. My sinuses started to hurt, but I didn't have a fever or cough. November 24th morning, I tested at home and I came back positive. We were shocked because we hadn't gotten COVID-19 before. I took my temperature for the next few days and for the next few days we didn't feel well. I also checked the blood oxygen a few times a day. It wasn't too serious. My concern was taking PAXLOVID because of my age. The problem was that it was the holiday so I called the next day and tried calling my internist group. They were closed, but within 3 days, my husband said he started to feel a little better and didn't think we needed to go to urgent care. We tested positive on November 24th, reasonably sick through the weekend, then Monday I was able to reach my doctor. My doctor said I should not stop taking my blood thinner to take PAXLOVID, but he said to continue watching my symptoms and be careful of shortness of breath. I didn't end up taking PAXLOVID and we did start to feel a little better. It would go back and forth between feeling better then not. That continued for a few more days then finally felt substantially better and I was not worried as much anymore. We did develop some fatigue during the infection, and I'm not sure that it's left yet. I don't feel terrible, but I do believe I'm still experiencing some fatigue.
Tired heart racing , been resting and my heart beats per minute have been over 100 up to 115 all day. Last night had chills.
HEAVY NOSE BLEEDING; This spontaneous report received from a parent concerned an 18 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 20-MAR-2021, the subject experienced heavy nose bleeding. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heavy nose bleeding on 20-MAR-2021. This report was non-serious.
No adverse event noted as of date/time 04/17/2017 at 12:27 pm Contacted CDC- Contacted CDC- No specific safety concerns. Higher chance for rash. ZOSTAVAX is very similar to VARIVAX vaccine, higher formulation.  Therefore, ZOSTAVAX vaccine given in error will count as VARIVAX #1. Patient will need VARIVAX #2 per regular schedule in 4 weeks. Reported in VAERS.
Mild body ache; Tenderness at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Mild body ache) and VACCINATION SITE PAIN (Tenderness at the injection arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MYALGIA (Mild body ache) and VACCINATION SITE PAIN (Tenderness at the injection arm). At the time of the report, MYALGIA (Mild body ache) and VACCINATION SITE PAIN (Tenderness at the injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information included acetaminophen and ibuprofen.
Pr received HIB vaccine on 2-22-10 developed 8 x 6.5 cm erythematous tender plaque + induration over R thigh 24 hours after injections. KEFLEX x 10 days.
C/o swelling of face. Seen in ER, given Benadryl, returned to school.
had 2 rounds of shingles, fully vaccinated/suspected vaccination failure; had 2 rounds of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 15th Apr 2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The case was reported by patient. The patient stated that he/she experienced 2 rounds of shingles after being fully vaccinated.  Additional Supportive Information: This case was considered as suspected vaccination failure since details regarding time to onset and laboratory confirmation of shingles not given.
2 3/4 x 2 3/4 " reddened, swollen, hot area at site of vaccine.
Pt presents to the ED with c/o right leg/calf pain and swelling. She also had a headache last week. She is concerned she may have a blood clot related to the Johnson & Johnson COVID vaccine, as the vaccine is currently on hold.
Received first dose of Moderna Vaccine on 3/17/2021 in the afternoon.  Injection into Left Arm given On 3/25/21 after morning shower noticed rash developing on left arm.   Then the rash started getting bigger and bigger.  It was warm to the touch and a bit itchy.
Pt had varicella vaccine x 2. Last administered in 2007. Had mild case of chickenpox diagnosed 11-5-10. Treated symptomatically.
10/31/2018 the patient's daughter let us know that the patient had pain, inflammation, redness and warmth at the vaccination site. We recommended to take some analgesics, use ice compresses, and go to the doctor if there is no improvement. On 11/1/18 patient doesn't feel good so went to the doctor for pain, fever, erythema, inflammation at the vaccination site and having high blood pressure. Doctor refers patient to the ER where they administer medicine, mark the affected erythema and inflammation area. They recommend cold compresses, to check the marked area and to go back to the doctor if it expands. Per daughter, according to what doctor explained was bursitis. Patient was released on the same day 11/01/2018 with monitoring instructions.
Severe arthritis pain in joints of feet, knees, wrists and fingers. More than normal and in more places than previously with no other physical impacts to any  joints or injury. Cortisone shots in the knees were given but still severe flare ups after
She received Tdap and the next morning had headache, tired, nausea, stomach ache, and chills.  Her temperature was 100 degrees at 10 AM and we called her Dr.; she took an Advil and temp went to 99.6 degrees. She was unable to do anything for 2 days and had the headache for over 3 days.  Fatigue continued for 2 days.  Headache was severe the first day and lessened but continued during the first 3 days.  The temperature, nausea and stomach ache was only on 5-4-2010.